Czechia, March 26 -- Czechia based AbbVie s.r.o. has secured contract from Krajska zdravotni, a.s. for Antineoplastic agents Supplies of medicinal preparations with the active ingredient VENETOCLAX 2025. The value of the contract is worth 2771011323 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....